Intellectual Property Law

Intellectual property applies to many different areas of the legal world. Applying for patents for work-products, by individual employees, trademark laws, copyrights, and how companies leverage their IP asset-rights over employees, are just a few of the many areas the National Law Review covers as it pertains to IP.

Intellectual Property Litigation

Intellectual Property disputes are a complex area of law, often involving deep dives into complex concepts to understand the issues at play. In the United States, the United States Patent and Trademark Office (USPTO/PTO) is the agency involved in registering patents and trademarks.   As part of the USPTO, the Patent Trial and Appeal Board settles patent disputes, using a variety of mechanisms to settle issues related to intellectual property.    Some of the mechanisms include inter partes review, post-grant procedures, and covered business method patent reviews.  Issues related to the America Invents Act are also settled through the PTAB. The National Law Review covers changes to standards held by the USPTO in litigation and other patent issues.  The Trademark Trial and Appeal Board settles disputes related to trademarks, such as an ex parte appeal from the denial of an application for registration by an examining attorney, and an inter partes opposition, cancellation, concurrent use, or interference proceeding.  Other agencies involved in patent disputes are the International Trade Commission (ITC) or the Federal Trade Commission (FTC).  The National Law Review covers patent news as it relates to Supreme Court (SCOTUS) and federal circuit courts’ appeals, as well as general patent litigation and new patent filings.

Intellectual Property in Drug Patents

Legal analysis related to drug patents and pharmaceuticals and the interplay with intellectual property issues are also covered by the National Law Review.   Drug patents, biosimilars, generic top-level domain registration (gTLD), trade secrets, non-compete clauses, and other patent application news are updated on the site regularly. Additionally, tangential issues that impact pharmaceutical companies, such as innovator liability and related litigation, are also analyzed by the legal experts who write for the National Law Review. 

Intellectual Property in an Employment Context

The National Law Review has legal analysis on the intersection between intellectual property rights and employment, and who owns ideas, the Work Made For Hire principle as well resulting litigation. Additionally, legislation such as the Defense of Trade Secrets Act and its impact on workplaces, and ongoing litigation related to the legislation is also covered.

International Intellectual Property

Visitors to the site will oftentimes read about international news as it relates to patent applications in the US, and internationally as well. Pharmaceutical patents in Brazil, medical device patent applications from the United Kingdom, or litigation from the European Union, China, India, and other international sectors, are often covered online. Visitors will find the latest coverage, news, and insights on patent applications and litigation, when visiting the National Law Review, for up-to-date practice-area news.


For hourly updates on the latest news about Intellectual Property Law, IP Litigation, Patent Legislation, and more, be sure to follow our IP Law Twitter feed, and sign up for complimentary e-news bulletins.

Intellectual property applies to many different areas of the legal world. Applying for patents for work-products, by individual employees, trademark laws, copyrights, and how companies leverage their IP asset-rights over employees, are just a few of the many areas the National Law Review covers as it pertains to IP.

Intellectual Property Litigation

Intellectual Property disputes are a complex area of law, often involving deep dives into complex concepts to understand the issues at play. In the United States, the United States Patent and Trademark Office (USPTO/PTO) is the agency involved in registering patents and trademarks.   As part of the USPTO, the Patent Trial and Appeal Board settles patent disputes, using a variety of mechanisms to settle issues related to intellectual property.    Some of the mechanisms include inter partes review, post-grant procedures, and covered business method patent reviews.  Issues related to the America Invents Act are also settled through the PTAB. The National Law Review covers changes to standards held by the USPTO in litigation and other patent issues.  The Trademark Trial and Appeal Board settles disputes related to trademarks, such as an ex parte appeal from the denial of an application for registration by an examining attorney, and an inter partes opposition, cancellation, concurrent use, or interference proceeding.  Other agencies involved in patent disputes are the International Trade Commission (ITC) or the Federal Trade Commission (FTC).  The National Law Review covers patent news as it relates to Supreme Court (SCOTUS) and federal circuit courts’ appeals, as well as general patent litigation and new patent filings.

Intellectual Property in Drug Patents

Legal analysis related to drug patents and pharmaceuticals and the interplay with intellectual property issues are also covered by the National Law Review.   Drug patents, biosimilars, generic top-level domain registration (gTLD), trade secrets, non-compete clauses, and other patent application news are updated on the site regularly. Additionally, tangential issues that impact pharmaceutical companies, such as innovator liability and related litigation, are also analyzed by the legal experts who write for the National Law Review. 

Intellectual Property in an Employment Context

The National Law Review has legal analysis on the intersection between intellectual property rights and employment, and who owns ideas, the Work Made For Hire principle as well resulting litigation. Additionally, legislation such as the Defense of Trade Secrets Act and its impact on workplaces, and ongoing litigation related to the legislation is also covered.

International Intellectual Property

Visitors to the site will oftentimes read about international news as it relates to patent applications in the US, and internationally as well. Pharmaceutical patents in Brazil, medical device patent applications from the United Kingdom, or litigation from the European Union, China, India, and other international sectors, are often covered online. Visitors will find the latest coverage, news, and insights on patent applications and litigation, when visiting the National Law Review, for up-to-date practice-area news.


For hourly updates on the latest news about Intellectual Property Law, IP Litigation, Patent Legislation, and more, be sure to follow our IP Law Twitter feed, and sign up for complimentary e-news bulletins.

Recent Intellectual Property, Patent, Trademark & Copyright News

Title
Date - Month Sort ascending Organization
22
Jun 23
False Advertising: Verifiably False Versus Subjective Opinion McDermott Will & Emery
22
Jun 23
Congress Proposes National Commission to Create AI Guardrails Sheppard, Mullin, Richter & Hampton LLP
22
Jun 23
It’s a Hard Rock Life: Guitar-Shaped Hotel Warrants Trademark, but Hilton Doesn’t McDermott Will & Emery
22
Jun 23
A Single Picture Database Is Worth a Thousand Statutory Damages Awards McDermott Will & Emery
22
Jun 23
First Rule of the PTAB? Play by the Rules
22
Jun 23
Under High Pressure: New Mechanism of Action Can’t Save Drug Administration Claims McDermott Will & Emery
22
Jun 23
What GDPR Requirements Does a Company that Uses Personal Information to Train an Artificial Intelligence (ai) Need to Meet? Greenberg Traurig, LLP
22
Jun 23
Australian Government Contemplates Asimov’s Omnibus K&L Gates
22
Jun 23
Inventorship Hosed Clean: Contribution, Corroboration and Collaboration Prove Joint Invention McDermott Will & Emery
22
Jun 23
Registering NFTs and Virtual Goods in the UK K&L Gates
22
Jun 23
Injury v. Discovery: When Copyright Holders Can Recover Damages for Infringement that Occurred More than Three Years Before Discovery of the Infringement Stark & Stark
21
Jun 23
Sometimes a Banana is Just a Banana: Morford v. Cattelan Greenberg Traurig, LLP
21
Jun 23
Bad Dog! SCOTUS Sides with Jack Daniel’s in Trademark Fight Over “Poop-Themed” Dog Toy Miller Canfield
21
Jun 23
NIL Tug of War: Evolving State NIL Laws and the Prospects of a Federal NIL Bill Bradley Arant Boult Cummings LLP
21
Jun 23
Training AI Models – Just Because It’s Your Data Doesn’t Mean You Can Use It Sheppard, Mullin, Richter & Hampton LLP
21
Jun 23
Generative AI and Patent Considerations – Part Two Sheppard, Mullin, Richter & Hampton LLP
21
Jun 23
Don't Miss Out On Patent Term -- Use The USPTO IDS PTA Safe Harbor Form Foley & Lardner LLP
20
Jun 23
Spilling Secrets: How to Pursue Damages in Trade Secrets Litigation [PODCAST] Epstein Becker & Green, P.C.
20
Jun 23
The EU’s “AI Act” Advances Vedder Price
19
Jun 23
The After Effects of the Music Modernization Act in the Digital Streaming Sphere Sheppard, Mullin, Richter & Hampton LLP
19
Jun 23
The inexplicable not explained in UK government’s Response to non-competition consultation Squire Patton Boggs (US) LLP
18
Jun 23
District Court Finding Doesn’t Preclude PTAB Proceeding McDermott Will & Emery
18
Jun 23
Absent Nexus Secondary Considerations Come in Second McDermott Will & Emery
18
Jun 23
Quack, Waddle and Duck: Order That Grants Injunctive Relief Is an Injunction McDermott Will & Emery
18
Jun 23
Draft Bill on Name, Image, and Likeness: Uniform Standard Contract, Medical Trust, NCAA Authority Jackson Lewis P.C.
17
Jun 23
How Big a Deal Is “Trump Too Small”? – SCOTUS Today Epstein Becker & Green, P.C.
16
Jun 23
The Nine Greatest Experts on the Internet, NOT! – The Supreme Court Considers the Algorithm in Google and Twitter Squire Patton Boggs (US) LLP
16
Jun 23
In Jack Daniel’s case, Supreme Court Rejects Ninth Circuit’s Expansive View of First Amendment Rogers Test Proskauer Rose LLP